FIELD: medicine.
SUBSTANCE: invention concerns glycoforms of VII factor and compositions of VII factor, characterized by modified configurations on basis of asparaginic oligosaccharide chains. In addition invention includes detection method applied for polypeptide glycoforms of VII factor, receiving method and disease treatment method as well.
EFFECT: identification of biologically active forms of recombinant VII factor.
53 cl, 5ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATE OF FACTOR VII POLYPEPTIDE, METHOD OF OBTAINING IT, ITS APPLICATION AND PHARMACEUTICAL COMPOSITION CONTAINING IT | 2003 |
|
RU2362807C2 |
| POLYPEPTIDE EXPRESSION VECTOR WITH SYALIDASE ACTIVITY, METHOD FOR PROVIDING SYALIDASE ACTIVITY IN CELL CULTURE AND METHOD FOR CONTROLLING PROPERTIES OF Fc-CONTAINING MOLECULES EXPRESSED IN CELL LINE | 2007 |
|
RU2466189C2 |
| METHODS RELATED TO CELL SURFACE GLYCOSYLATION | 2008 |
|
RU2475751C2 |
| METHODS RELATING TO MODIFIED GLYCANS | 2009 |
|
RU2526250C2 |
| METHOD FOR PREPARING ANTIBODIES HAVING IMPROVED PROPERTIES | 2011 |
|
RU2604811C2 |
| STUDY OF N-GLYCANS WITH APPLICATION OF EXOGLYCOSIDASES | 2008 |
|
RU2475759C2 |
| SEPARATION METHOD FOR FUCOSYLATED ANTIBODIES | 2012 |
|
RU2650873C2 |
| PRODUCING GLYCOPROTEINS | 2007 |
|
RU2463345C2 |
| PRODUCTION OF GLYCOPROTEINS WITH MODIFIED FUCOSYLATION | 2008 |
|
RU2479629C2 |
| LYSOSOMAL DISEASE ACCUMULATION ENZYME | 2017 |
|
RU2741116C2 |
